ArticleBMC infectious diseases2026
Time-associated phenotypic changes related to virulence and immune interaction of Staphylococcus aureus during relapsing infection within individual hosts.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundStaphylococcus aureus is a major cause of relapsing infection. However, how its phenotypic traits change over time within individual hosts during relapsing infection remains incompletely characterized.
methodsIn this study, we analyzed five longitudinal S. aureus isolates obtained from two patients with relapsing infection to investigate within-host phenotypic and genomic changes. Whole-genome sequencing was combined with a series of phenotypic assays, including antimicrobial susceptibility testing, erythrocyte lysis assays, whole-blood survival assays, neutrophil extracellular trap (NET) degradation analysis, growth curve determination, antibiotic time-kill assays with levofloxacin, and macrophage phagocytosis and intracellular survival in iBMDMs and murine bloodstream infection models.
resultsIsolates recovered from each patient were clonally related (ST630/t377 and ST239/t030). Across both clinical trajectories, later isolates showed reduced in vitro growth. Virulence-associated readouts changed over time, including reduced erythrocyte lysis and lower mouse mortality for later isolates in one patient, whereas changes were not uniform between patients. Later isolates displayed improved survival in whole blood, and sequential isolates from one patient showed qualitatively increased NET-degrading activity. Antimicrobial susceptibility profiles remained largely stable, but time-kill assays indicated incomplete eradication under levofloxacin exposure, and later isolates exhibited reduced macrophage phagocytosis and increased intracellular survival.
conclusionOur findings suggest that S. aureus isolates recovered sequentially from individual patients may undergo coordinated, time-associated phenotypic changes during relapsing infection. These observations provide insight into time-associated phenotypic variation of S. aureus during relapsing infection within individual hosts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.